Filing Details
- Accession Number:
- 0001179110-19-008728
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-19 13:53:04
- Reporting Period:
- 2019-07-15
- Accepted Time:
- 2019-07-19 13:53:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1477449 | Teladoc Health Inc. | TDOC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1322295 | A Peter Mcclennen | C/O Teladoc Health, Inc. 2 Manhattanville Road, Suite 203 Purchase NY 10577 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-07-15 | 29,412 | $0.00 | 29,412 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-07-15 | 13,753 | $70.99 | 15,659 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-07-17 | 7,829 | $69.10 | 7,830 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-07-17 | 7,830 | $69.07 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2019-07-15 | 29,412 | $0.00 | 29,412 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Footnotes
- Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019.
- Represents the weighted average price of transactions ranging from $68.90 to $69.32. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
- On July 14, 2017, the reporting person was was granted 58,824 restricted stock units, vesting in two equal annual installments beginning on July 14, 2018.
Billionaire Hedge Funds
